BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6678159)

  • 1. Combined effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkey aortas.
    Wissler RW; Vesselinovitch D
    Appl Pathol; 1983; 1(2):89-96. PubMed ID: 6678159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta.
    Kouzuma R; Tasaki H; Komura T; Nakashima Y; Kuroiwa A; Tanimoto A; Koide O
    Artery; 1995; 21(6):337-51. PubMed ID: 8833232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotive effect of elastase on regression of aortic atherosclerosis in cholesterol-fed quails.
    Toda T; Hokama S; Nagamine M; Takei H
    Exp Pathol; 1989; 36(4):201-9. PubMed ID: 2767211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of indomethacin on serum lipids, lipoproteins, prostaglandins and the extent and severity of atherosclerosis in rhesus monkeys.
    Dhawan V; Ganguly NK; Majumdar S; Chakravarti RN
    Can J Cardiol; 1992 Apr; 8(3):306-12. PubMed ID: 1576566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
    Kitamoto S; Nakano K; Hirouchi Y; Kohjimoto Y; Kitajima S; Usui M; Inoue S; Egashira K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1522-8. PubMed ID: 15178560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.
    Walldius G; Carlson LA; Erikson U; Olsson AG; Johansson J; Mölgaard J; Nilsson S; Stenport G; Kaijser L; Lassvik C
    Am J Cardiol; 1988 Jul; 62(3):37B-43B. PubMed ID: 3293415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of captopril on atherosclerosis in cynomolgus monkeys.
    Aberg G; Ferrer P
    J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S65-72. PubMed ID: 1694934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia.
    Jackson JM; Lee HA
    Atherosclerosis; 1984; 51(2-3):189-97. PubMed ID: 6743378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for regression of advanced atherosclerotic plaques.
    Wissler RW
    Artery; 1979 May; 5(5):398-408. PubMed ID: 262163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aneurysm formation in experimental atherosclerosis: relationship to plaque evolution.
    Zarins CK; Glagov S; Vesselinovitch D; Wissler RW
    J Vasc Surg; 1990 Sep; 12(3):246-56. PubMed ID: 2398583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
    Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI
    Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic lysosomal hydrolases and pathological alterations in hypertensive and/or atherogenic diet fed rhesus monkeys.
    Dhaunsi GS; Majumdar S; Chakravarti RN
    J Exp Pathol; 1992; 6(1-2):1-9. PubMed ID: 1625032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
    Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
    Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of individualized long-term therapy with niacin and probucol in reduction of serum cholesterol.
    Cohen L; Morgan J
    J Fam Pract; 1988 Feb; 26(2):145-50. PubMed ID: 3339318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis in the tongue of the rhesus monkey.
    Mostofi RS; Goepp RA
    J Dent Res; 1981 Nov; 60(11):1876-85. PubMed ID: 6945326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-induced atherosclerosis in cynomolgus monkey aorta and regression by the sixth-month observation.
    Yamada T; Yoshikuni Y; Taira M; Yoshida-Suzuka H; Kimura K; Sakurai I; Takenaka O
    Angiology; 1992 Dec; 43(12):1008-19. PubMed ID: 1466482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of probucol on xanthomata regression in familial hypercholesterolemia.
    Yamamoto A; Matsuzawa Y; Yokoyama S; Funahashi T; Yamamura T; Kishino B
    Am J Cardiol; 1986 Jun; 57(16):29H-35H. PubMed ID: 3728307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of diet and probucol.
    Rapado A; Castrillo JM; Díaz-Curiel M
    Arch Intern Med; 1979 Sep; 139(9):1062-3. PubMed ID: 475528
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of various dietary regimens and cholestyramine on aortic glycosaminoglycans during regression of atherosclerotic lesions in rhesus monkeys.
    Radhakrishnamurthy B; Ruiz HA; Dalferes ER; Vesselinovitch D; Wissler RW; Berenson GS
    Atherosclerosis; 1979 May; 33(1):17-28. PubMed ID: 111684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.